摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol | 69912-75-0

中文名称
——
中文别名
——
英文名称
2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
英文别名
——
2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol化学式
CAS
69912-75-0
化学式
C16H16O6
mdl
——
分子量
304.29
InChiKey
ZHDMPVIDHWJGTN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >156°C (dec.)
  • 溶解度:
    丙酮(微溶,超声处理),甲醇(微溶)
  • 物理描述:
    Solid

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    99.4
  • 氢给体数:
    4
  • 氢受体数:
    6

文献信息

  • Light stabilizing liquid matter containing 2- (2-hydroxy-3-alpha-cumyl-5-tert-octylphenyl) -2h-benzotriazole
    申请人:Su Ching-Yie
    公开号:US20080156227A1
    公开(公告)日:2008-07-03
    A light stabilizing liquid matter, that can be added to a composition to be stabilized and that has a storage stability high enough for storage before being added to the composition, includes a product formed by mixing: (A) 2-(2-hydroxy-3-α-cumyl-5-tert-octylphenyl)-2H-benzotriazole with (B) at least one benzotriazole compound other than 2-(2-hydroxy-3-α-cumyl-5-tert-octylphenyl)-2H-benzotriazole plus a hindered amine compound, or with (B′) at least one compound selected from the group consisting of a benzotriazole compound other than 2-(2-hydroxy-3-α-cumyl-5-tert-octylphenyl)-2H-benzotriazole, and a hindered amine compound, and (C) an anti-oxidant including at least one compound selected from the group consisting of a phosphite compound and a phenolic compound.
    一种轻质稳定液体,可添加到需要稳定的混合物中,并具有足够的储存稳定性,以在添加到混合物之前进行储存。该液体包括以下混合物制成的产品:(A) 2-(2-羟基-3-α-烷基-5-叔辛基苯基)-2H-苯并三唑与(B) 至少一种苯并三唑化合物,但不包括2-(2-羟基-3-α-烷基-5-叔辛基苯基)-2H-苯并三唑,再加上一种受阻胺化合物,或者与(B′) 至少一种从苯并三唑化合物(但不包括2-(2-羟基-3-α-烷基-5-叔辛基苯基)-2H-苯并三唑)和受阻胺化合物组成的化合物,以及(C) 至少一种从磷酸酯化合物和酚类化合物组成的抗氧化剂。
  • Boosting immunity
    申请人:Schmitz H. Harold
    公开号:US20080090898A1
    公开(公告)日:2008-04-17
    The invention relates to compositions, and methods of use thereof, for boosting immunity, e.g. innate immunity, in a subject in need thereof comprising administering to the subject certain polyphenols such as flavanols, procyanidins, or pharmaceutically acceptable salts or derivatives thereof.
    本发明涉及一种用于增强免疫力的组合物及其使用方法,例如增强天然免疫力,适用于需要该类增强免疫力的受试者。该组合物包括给受试者注射一定的多酚类物质,例如黄烷醇、原花青素或药学上可接受的其盐或衍生物。
  • Compositions and methods of use of derivatized flavanols
    申请人:Kwik-Uribe L. Catherine
    公开号:US20060293259A1
    公开(公告)日:2006-12-28
    The invention relates to compositions containing derivatized flavanols such as methylated flavanols, and methods of use thereof for prophylactic or therapeutic treatment of a human or a veterinary animal for example as anti-platelet agents.
    本发明涉及含有衍生化黄烷醇的组合物,例如甲基化黄烷醇,以及其用于预防或治疗人类或兽医动物的方法,例如作为抗血小板剂的用途。
  • GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF
    申请人:Kaleido Biosciences, Inc.
    公开号:EP3354282A1
    公开(公告)日:2018-08-01
    Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    本发明提供了可选择包含微量营养素、多酚、益生元、益生菌或其他制剂的聚糖疗法制剂、药物组合物及其医用食品,以及制造方法。还提供了使用所述糖治疗剂的方法,例如用于调节人类胃肠道微生物群和治疗菌群失调。
  • Glycan therapeutics and related methods thereof
    申请人:KALEIDO BIOSCIENCES, INC.
    公开号:US10314853B2
    公开(公告)日:2019-06-11
    Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    本发明提供了可选择包含微量营养素、多酚、益生元、益生菌或其他制剂的聚糖疗法制剂、药物组合物及其医用食品,以及制造方法。还提供了使用所述糖治疗剂的方法,例如用于调节人类胃肠道微生物群和治疗菌群失调。
查看更多